|
|
|
|
|
 |
|
|
Submit your abstract before 31 January 2012. |
|
|
|
 |
|
|
 |
|
|
Find out more about the speakers’ timeline and schedule. |
|
|
|
|
|
|
 |
|
|
Enjoy promotion for the early bird registration until 31 January 2012. |
|
|
|
|
| Summit Information > Welcome Message |
|
 Dear Colleagues,
It is with great pleasure that I announce the fourth Asian Oncology Summit in Singapore on April 13–15, 2012. Please save the date in your diaries. Over the past 3 years, the Summit has grown in reputation and has fast-established itself as an annual must-attend multidisciplinary event for oncologists from the Asia-Pacific region.
The 2012 programme is being developed by a newly formed Scientific Committee comprising prominent Asian oncologists to ensure content is focused closely on local priorities. The theme for the Summit will be Improving patient outcomes through individualised medicine and sees, for the first time, the incorporation of a preclinical track containing lectures on molecular pathology and translational medicine. Other tracks and lectures will be dedicated to breast, thoracic, gastrointestinal, head and neck, brain, gynaecological, haematological, and genitourinary cancers, melanoma and sarcoma, supportive and palliative oncology, and prevention. Finally, 2012 sees the reintroduction of a series of workshops designed to create Asia-specific treatment guidelines that proved to be extremely popular at the inaugural Summit in 2009.
Please check this website frequently for updates in the programme or to sign the AOS mailing list, for details on how to submit abstracts, for registration and sponsorship information, and for events in and around the Summit. I hope you decide to once again make the Asian Oncology Summit, and the vibrant city state of Singapore, an integral part of your travel plans for 2012.
Dr David Collingridge
Executive Chair, Asian Oncology Summit
Editor-in-Chief, The Lancet Oncology |
|
